These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23919252)

  • 21. Not so selective serotonin reuptake inhibitors.
    Stahl SM
    J Clin Psychiatry; 1998 Jul; 59(7):343-4. PubMed ID: 9714261
    [No Abstract]   [Full Text] [Related]  

  • 22. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical pharmacology of citalopram.
    Popik P
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):4S-22S. PubMed ID: 10507505
    [No Abstract]   [Full Text] [Related]  

  • 24. Organic hypomania secondary to sibutramine-citalopram interaction.
    Benazzi F
    J Clin Psychiatry; 2002 Feb; 63(2):165. PubMed ID: 11874219
    [No Abstract]   [Full Text] [Related]  

  • 25. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects.
    Smith GS; Ma Y; Dhawan V; Gunduz H; Carbon M; Kirshner M; Larson J; Chaly T; Belakhleff A; Kramer E; Greenwald B; Kane JM; Laghrissi-Thode F; Pollock BG; Eidelber D
    Synapse; 2002 Aug; 45(2):105-12. PubMed ID: 12112403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT2C receptors are involved in the discriminative stimulus effects of citalopram in rats.
    Millan MJ; Girardon S; Dekeyne A
    Psychopharmacology (Berl); 1999 Mar; 142(4):432-4. PubMed ID: 10229070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
    Sánchez C
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing.
    Inoue T; Nakagawa S; Izumi T; Kitaichi Y; Koyama T
    Eur J Pharmacol; 2006 Jul; 540(1-3):91-5. PubMed ID: 16714013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressive effect of citalopram on plasma concentrations of thromboxane B2.
    Richter T; Alusik S; Paluch Z; Burianova I; Cybulja A; Sadilkova L
    Scand J Clin Lab Invest; 2015 Nov; 75(7):615-20. PubMed ID: 26205292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citalopram for verbal agitation in patients with dementia.
    Kim KY; Bader GM; Jones E
    J Geriatr Psychiatry Neurol; 2000; 13(2):53-5. PubMed ID: 10912724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are pharmacokinetic drug interactions with the SSRIs an issue?
    Brøsen K
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():23-7. PubMed ID: 8732441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography.
    Smith GS; Ma Y; Dhawan V; Chaly T; Eidelberg D
    Synapse; 2009 Jan; 63(1):1-6. PubMed ID: 18925655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citalopram: another SSRI antidepressant.
    Price PL
    S D J Med; 1999 Mar; 52(3):99-100. PubMed ID: 10100452
    [No Abstract]   [Full Text] [Related]  

  • 35. There is a new antidepressant escitalopram (Lexapro) that is a cousin of citalopram (Celexa). How are these two different and does the newer drug have any advantages?
    Harv Ment Health Lett; 2003 Jul; 20(1):8. PubMed ID: 12888468
    [No Abstract]   [Full Text] [Related]  

  • 36. Citalopram--a review of pharmacological and clinical effects.
    Bezchlibnyk-Butler K; Aleksic I; Kennedy SH
    J Psychiatry Neurosci; 2000 May; 25(3):241-54. PubMed ID: 10863884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
    Hjorth S; Westlin D; Bengtsson HJ
    Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor.
    Bismuth-Evenzal Y; Roz N; Gurwitz D; Rehavi M
    Biochem Pharmacol; 2010 Nov; 80(10):1546-52. PubMed ID: 20696140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex.
    Kleijn J; Cremers TI; Hofland CM; Westerink BH
    Neurosci Res; 2011 Jul; 70(3):334-7. PubMed ID: 21420449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K; Naranjo CA
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):275-83. PubMed ID: 11532381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.